Healios KK
TSE:4593

Watchlist Manager
Healios KK Logo
Healios KK
TSE:4593
Watchlist
Price: 298 JPY 1.02% Market Closed
Market Cap: 26.9B JPY
Have any thoughts about
Healios KK?
Write Note

Wall Street
Price Targets

Price Targets Summary
Healios KK

Wall Street analysts forecast Healios KK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Healios KK is 357 JPY with a low forecast of 303 JPY and a high forecast of 420 JPY.

Lowest
Price Target
303 JPY
2% Upside
Average
Price Target
357 JPY
20% Upside
Highest
Price Target
420 JPY
41% Upside
Healios KK Competitors:
Price Targets
UTHR
United Therapeutics Corp
10% Upside
206650
EuBiologics Co Ltd
43% Upside
000403
Pacific Shuanglin Bio pharmacy Co Ltd
55% Upside
ALGEN
Genoway SA
77% Upside
CMRX
Chimerix Inc
93% Upside
HALO
Halozyme Therapeutics Inc
14% Upside
IFRX
InflaRx NV
241% Upside
SGMO
Sangamo Therapeutics Inc
366% Upside

Revenue
Forecast

Revenue Estimate
Healios KK

For the last 8 years the compound annual growth rate for Healios KK's revenue is 3%. The projected CAGR for the next 3 years is 133%.

3%
Past Growth
133%
Estimated Growth
Estimates Accuracy
17%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Healios KK

Operating Income forecast
is not available for
Healios KK

Net Income
Forecast

Net Income Estimate
Healios KK

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-34%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Healios KK's stock price target?
Price Target
357 JPY

According to Wall Street analysts, the average 1-year price target for Healios KK is 357 JPY with a low forecast of 303 JPY and a high forecast of 420 JPY.

What is Healios KK's Revenue forecast?
Projected CAGR
133%

For the last 8 years the compound annual growth rate for Healios KK's revenue is 3%. The projected CAGR for the next 3 years is 133%.

Back to Top